Wissam Khoury, DPM
Podiatrist · Cleveland, OHNPI 1104886910
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,600 of the $5,506 with a category attached, or 65.4%. Osiris Therapeutics Inc. accounts for 66.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $4,697 and has fallen 99.7% since, to $15 in 2025.
Across 44 payments — averaging $125.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osiris Therapeutics Inc.$4K
- Medtronic$893
- Smith+Nephew$564
- Abbott$140
- Cardiovascular Systems Inc.$68
- Rock Medical Orthopedics, Inc.$40
- plus $116 from 7 others
What the payments were for
- Consulting fees$3,60065%
- Travel & lodging$631%
- Food & beverage$1,84333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osiris Therapeutics Inc. | 3 | $3,684 |
| Medtronic(2 entities) | 11 | $893 |
| Smith+Nephew | 19 | $564 |
| Abbott | 1 | $140 |
| Cardiovascular Systems Inc. | 1 | $68 |
| Rock Medical Orthopedics, Inc. | 1 | $40 |
| Amgen | 2 | $29 |
| Acell, Inc. | 1 | $16 |
| Organogenesis Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $14 |
| Stryker | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GrafixPL$3,716
- Stravix$3,600
- Grafix$3,600
- JETi All In One Non-Sterile Kit$140
- Allevyn Life$128
- PICO 7 Single Use Negative Pressure Wound Therapy$128
- IN.PACT Admiral$115
How this compares
$5,506 in reported general payments places this provider in the 80th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 27 | $634 |
| Ammonium Lactate | 15 | $380 |
| Triamcinolone Acetonide | 12 | $90 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Cleveland
- Michael MaierCleveland$120K
- James HayesCleveland$31K
- Nathan RossiCleveland$31K
- Brendan JohnsonCleveland$9K
- Bryan CaldwellCleveland$8K
- Mark HardyAvon$2.1M
- Lawrence DidomenicoBoardman$1.1M
- Ralph NapolitanoNew Albany$494K
- Thomas GronerNiles$193K
- Eric StortsLondon$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.